World's Best Scientists 2026 revealed!
Guido Ferlazzo

Guido Ferlazzo

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 57 3605 3322 146 138 167 13119

Guido Ferlazzo publications per year

The chart shows the history of publications by Guido Ferlazzo between 1955 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Guido Ferlazzo published across 71 years, from 1955 to 2025, averaging 2.4 papers a year. Output peaked at 12 publications in 2021. 10 of the 172 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1955 to 2025. Vertical axis: number of publications, 0 to 12. Peak 12 publications in 2021. 1955: 1 publication 1956: 0 publications 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 3 publications 1992: 2 publications 1993: 3 publications 1994: 1 publication 1995: 1 publication 1996: 5 publications 1997: 3 publications 1998: 0 publications 1999: 4 publications 2000: 4 publications 2001: 3 publications 2002: 3 publications 2003: 8 publications 2004: 4 publications 2005: 3 publications 2006: 3 publications 2007: 4 publications 2008: 6 publications 2009: 4 publications 2010: 10 publications 2011: 4 publications 2012: 5 publications 2013: 9 publications 2014: 8 publications 2015: 9 publications 2016: 5 publications 2017: 5 publications 2018: 6 publications 2019: 5 publications 2020: 7 publications 2021: 12 publications 2022: 6 publications 2023: 6 publications 2024: 3 publications 2025: 7 publications
1955 2025

172 publications in total across all disciplines

View publications per year as a table
Guido Ferlazzo: publications per year, 1955 to 2025
Year Publications
1955 1
1956 0
1957 0
1958 0
1959 0
1960 0
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 0
1990 0
1991 3
1992 2
1993 3
1994 1
1995 1
1996 5
1997 3
1998 0
1999 4
2000 4
2001 3
2002 3
2003 8
2004 4
2005 3
2006 3
2007 4
2008 6
2009 4
2010 10
2011 4
2012 5
2013 9
2014 8
2015 9
2016 5
2017 5
2018 6
2019 5
2020 7
2021 12
2022 6
2023 6
2024 3
2025 7
Total 172
Download as CSV

Guido Ferlazzo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guido Ferlazzo sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 162–171 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 167 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166 167
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Guido Ferlazzo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guido Ferlazzo sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194 57
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Guido Ferlazzo is affiliated with the University of Messina in Italy. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, and Surgery.

The main topics of their work include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Immune cells in cancer
  • T-cell and B-cell Immunology
  • SARS-CoV-2 and COVID-19 Research

Guido Ferlazzo has published scientific papers in a range of established venues. Their frequent publication venues are:

  • Frontiers in Immunology
  • European Journal of Immunology
  • Immunology Letters
  • Hepatology
  • Cancers

Some recent papers include:

  • Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade (2022, Frontiers in Immunology)
  • Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations (2020, Expert Review of Vaccines)
  • Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer (2020, Frontiers in Immunology)
  • Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 (2020, European Journal of Immunology)
  • Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells (2022, Pharmaceutics)

Frequent collaborators in research include:

  • Claudia De Pasquale
  • Stefania Campana
  • Paolo Carrega
  • Gaetana Pezzino
  • Riccardo Cavaliere

Best Publications

  • Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

    Guido Ferlazzo;Ming L. Tsang;Lorenzo Moretta;Lorenzo Moretta;Giovanni Melioli

  • The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic

    Guido Ferlazzo;Dolca Thomas;Shao Lee Lin;Kiera Goodman

  • Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.

    Guido Ferlazzo;Maggi Pack;Dolca Thomas;Casper Paludan

  • CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation

    Chiara Romagnani;Kerstin Juelke;Michela Falco;Barbara Morandi

  • NK cells at the interface between innate and adaptive immunity

    A Moretta;E Marcenaro;S Parolini;G Ferlazzo

  • Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells

    Paolo Carrega;Barbara Morandi;Roberta Costa;Guido Frumento

  • NK Cell Compartments and Their Activation by Dendritic Cells

    Guido Ferlazzo;Christian Münz

  • Effector and regulatory events during natural killer-dendritic cell interactions.

    Lorenzo Moretta;Lorenzo Moretta;Guido Ferlazzo;Cristina Bottino;Massimo Vitale

  • The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

    Mariella Della Chiesa;Massimo Vitale;Simona Carlomagno;Guido Ferlazzo

  • CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells

    Kerstin Juelke;Monica Killig;Merlin Luetke-Eversloh;Eliana Parente

  • NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

    Paolo Carrega;Fabrizio Loiacono;Emma Di Carlo;Angelo Scaramuccia

  • The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.

    Guido Ferlazzo;Barbara Morandi;Antonella D'Agostino;Raffaella Meazza

  • The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer

    Antonino Bruno;Chiara Focaccetti;Arianna Pagani;Andrea S. Imperatori

  • CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.

    Paolo Carrega;Irene Bonaccorsi;Emma Di Carlo;Barbara Morandi

  • Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application

    Nadia Sessarego;Alessia Parodi;Marina Podestà;Federica Benvenuto

  • Natural killer cell distribution and trafficking in human tissues.

    Paolo Carrega;Guido Ferlazzo

  • NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion

    Barbara Morandi;Gwenola Bougras;William A. Muller;Guido Ferlazzo;Guido Ferlazzo

  • Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells

    Guido Ferlazzo;Barbara Morandi

  • A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis

    Antonino Bruno;Guido Ferlazzo;Adriana Albini;Douglas M. Noonan

  • The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

    Stefania Laurent;Paola Queirolo;Silvia Boero;Sandra Salvi

Frequent Co-Authors

Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Alessandro Moretta
Alessandro Moretta University of Genoa
Christian Münz
Christian Münz University of Zurich
Claudia Cantoni
Claudia Cantoni University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Daniela Pende
Daniela Pende University of Genoa
Michela Falco
Michela Falco Istituto Giannina Gaslini
Adriana Albini
Adriana Albini University of Milano-Bicocca
Katia Georgopoulos
Katia Georgopoulos Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career opportunities, especially in healthcare and research. Many students interested in immunology also explore online degrees that complement their knowledge, such as nursing programs designed for various entry points.

For those without prior healthcare experience, the best online bsn programs for non nurses offer a flexible path to become a registered nurse while building foundational medical knowledge that benefits immunology applications.

If accelerating your nursing career is a priority, considering the easiest accelerated nursing programs to get into can provide a quicker route to gaining critical skills needed for patient care in immunology-related fields.

Entry-level licensing is another viable route. Many students start with practical nursing through lpn schools easy to get into, which helps establish a solid clinical foundation.

For advanced practice roles, exploring the easiest np programs to get into allows students to elevate their expertise and contribute more directly to immunology research and patient care.

These related programs illustrate how dynamic and versatile career pathways connected to immunology can be, especially when combined with online education options that cater to different backgrounds and schedules.

Best Scientists Citing Guido Ferlazzo

Trending Scientists

Recently Published Articles